Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors

Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors

Heparin has already been found in a variety of animal tissues but only few of them became effective sources for production of pharmaceutical preparations. Here, we correlate physical-chemical features and anticoagulant activities of structurally similar heparins employed in the past (from bovine lun...

Full description

Bibliographic Details
Main Authors:	Stephan N.M.C.G. Oliveira, Ana M.F. Tovar, Francisco F. Bezerra, Adriana A. Piquet, Nina V. Capillé, Paloma S. Santos, Eduardo Vilanova, Paulo A.S. Mourão
Format:	Article
Language:	English
Published:	Georg Thieme Verlag KG 2022-10-01
Series:	TH Open
Subjects:	anticoagulant heparin low-molecular-weight heparin physical-chemical concepts thromboembolism
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/a-1946-0325

Similar Items

Approaches to Assure Similarity between Pharmaceutical Heparins from Two Different Manufacturers
by: Francisco Felipe Bezerra, et al.
Published: (2023-03-01)

Pharmacokinetic, Hemostatic, and Anticancer Properties of a Low-Anticoagulant Bovine Heparin
by: Roberto P. Santos, et al.
Published: (2022-04-01)

Unfractionated Heparin in SARS-CoV-2 Pneumonia: Ischemic Stroke Case Report
by: Aslan Efendizade, et al.
Published: (2020-09-01)

Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass model /
by: Walenga, J. M.

Studies on the anticoagulant, antimetastatic and heparin-binding properties of ghilanten-relared inhibitors /
by: Brankamp, R. G.

Heparins Sourced From Bovine and Porcine Mucosa Gain Exclusive Monographs in the Brazilian Pharmacopeia
by: Eduardo Vilanova, et al.
Published: (2019-02-01)

Spontaneous Breast Haematoma after Heparin Anticoagulation
by: Imran Yaseen Gani, et al.
Published: (2020-06-01)

Not Just Anticoagulation—New and Old Applications of Heparin
by: Lixuan Zang, et al.
Published: (2022-10-01)

Therapeutic inefficacy of protocol driven intravenous unfractionated heparin infusion in the current era
by: Kayla Torppey, et al.
Published: (2023-10-01)

How to improve the management of a patient with heparin-induced thrombocytopenia?
by: Anetta Undas
Published: (2019-11-01)

Preparation, Anticoagulant and Antioxidant Properties of Glucosamine-Heparin Salt
by: Qin Miao, et al.
Published: (2022-10-01)

Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”: Keep calm and carry on
by: Sven R. Olson, et al.
Published: (2019-07-01)

Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
by: V. O. Bitsadze, et al.
Published: (2021-07-01)

Pharmacological properties of hirudin and its derivatives : potential clinical advantages over heparin /
by: 422288 Monreal, Manuel, et al.

Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland
by: Lorenzo A. Alberio, et al.
Published: (2020-04-01)

The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19
by: Heloísa Antoniella Braz-de-Melo, et al.
Published: (2021-04-01)

Updates in Anticoagulation Therapy Monitoring
by: Hannah L. McRae, et al.
Published: (2021-03-01)

Bivalirudin for cardiac catheterization in a pediatric patient with religious objection to the use of porcine-derived heparin
by: A. Caskey, et al.
Published: (2021-08-01)

Strategies to Overcome Heparins’ Low Oral Bioavailability
by: Ana Rita Neves, et al.
Published: (2016-06-01)

Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting
by: Harry Menon, et al.
Published: (2018-10-01)

OPTIONS FOR USE OF APPROPRIATE ANTICOAGULANT THERAPY IN PATIENTS WITH THERMAL INJURY WITH A HIGH RISK OF THROMBOEMBOLIC COMPLICATIONS DEVELOPMENT ASSOCIATED WITH RECURRENT INTESTINAL BLEEDING
by: V. S. Borisov, et al.
Published: (2016-02-01)

Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials
by: Corinne Frere, et al.
Published: (2022-05-01)

The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative literature review
by: Aleksandra Frackiewicz, et al.
Published: (2023-05-01)

Heparin Mimetics: Their Therapeutic Potential
by: Shifaza Mohamed, et al.
Published: (2017-10-01)

Comparing the Effects of Three Heparinization Methods of Hemodialysis Set on the Amount of Clot Formation during Hemodialysis
by: M Kazemi, et al.
Published: (2005-07-01)

The use of heparin and heparin-like molecules in cancer treatment: a review
by: Johnny Atallah, et al.
Published: (2020-01-01)

Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue
by: O. D. Ostroumova, et al.
Published: (2020-07-01)

Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin : comparison with heparin and recombinant hirudin /
by: Berry, Christopher N.

Strategies involving low-molecular-weight heparin for the treatment and prevention of venous thromboembolism in patients with obesity: A systematic review and meta-analysis
by: Junjie Liu, et al.
Published: (2023-03-01)

REPRODUCTION PERFORMANCE OF RABBITS BY INCUBATED SEMEN WITH HEPARIN IN INDUSTRY RABBIT FARM
by: M. FIK, et al.
Published: (2023-10-01)

“In Less than No Time”: Feasibility of Rotational Thromboelastometry to Detect Anticoagulant Drugs Activity and to Guide Reversal Therapy
by: Vittorio Pavoni, et al.
Published: (2022-03-01)

Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins
by: Aleksandra Jakimczuk, et al.
Published: (2022-04-01)

Treatment of venous thromboembolism – effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management
by: Hass Bastian, et al.
Published: (2012-12-01)

Retrospective evaluation of chemical venous thromboembolism prophylaxis in traumatic brain injury
by: Emily K. Hollfelder, et al.
Published: (2023-06-01)

Heparin and SARS-CoV-2: Multiple Pathophysiological Links
by: Pierpaolo Di Micco, et al.
Published: (2021-12-01)

Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure
by: Benjamin Seeliger, et al.
Published: (2021-01-01)

Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications
by: Marco Heestermans, et al.
Published: (2022-10-01)

Continuous Infusion versus Intermittent Intravenous Heparin Injection Ef-fect on Coagulation State after Peripheral Vascular Surgery
by: Enayat Yadollahi, et al.
Published: (2011-10-01)

Recombinant Heparin—New Opportunities
by: Charles Alexander Glass
Published: (2018-12-01)

Safety of low-dose anticoagulation in extracorporeal membrane oxygenation using the Permanent Life Support System: a retrospective observational study
by: Kyungsub Song, et al.
Published: (2023-07-01)